Plato Investment Management Ltd Invests $1.03 Million in Astera Labs, Inc. $ALAB

Plato Investment Management Ltd bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,141 shares of the company’s stock, valued at approximately $1,028,000.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. grew its holdings in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after acquiring an additional 84,365 shares during the last quarter. Atreides Management LP raised its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. State Street Corp raised its stake in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Finally, Fred Alger Management LLC lifted its position in shares of Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. UBS Group reissued a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Roth Capital reiterated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Finally, Susquehanna lifted their target price on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $303.44 on Wednesday. The stock has a market cap of $52.64 billion, a price-to-earnings ratio of 150.22 and a beta of 3.84. The company has a 50 day moving average of $356.72 and a 200-day moving average of $242.75. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 631,979 shares of company stock valued at $215,479,247 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.